EP10.0藥典： 1、Piperacillin Sodium EP10.0 2、替加環(huán)素Tigecycline EP10.0 3、阿托品atropine EP10.0 4、硫酸阿托品 EP10.0 5、2.6.31 EP10.0 6、EP10.0: Salmeterol Xinafoate 7、EP10.0: Preparations for inhalation 8、EP10.0: Pressurised pharmaceutical preparations" 9、EP10:ceftazidime 10、Formoterol Fumarate EP10.0 11、乳酸依沙吖啶Ethacridine lactate monohydrate EP10.0 12、Aspartame的EP10.0標準 13、EP10.0 3.1.9 14、perindopril tert-butylamine的EP10.1標準 15、CALCIUM LEVOFOLINATE HYDRATE EP10.0 16、Deslanoside EP10 17、Inhalation powders EP10 18、Fluconazole EP10 19、Nifedipine EP10 20、Calcium Dobesilate Monohydrate 羥苯磺酸鈣原料藥EP10.0的標準 21、EP10.0 Ipratropium bromide 22、Voriconazole EP10.0 23、Magnesium Stearate硬脂酸鎂 EP10.0 24、Colloidal Anhydrous Silica膠態(tài)無水二氧化硅 EP10.0 25、Purified water 純化水 EP10.0 26、Povidone (K-90) 聚維酮 (K-90) EP10.0 27、Hydroxypropyl cellulose (EF)羥丙纖維素 (EF) EP10.0 28、HPMC E-15羥丙甲纖維素E-15 EP10.0 29、Purified Talc 滑石粉 EP10.0 30、Pregelatinised Starch 預膠化淀粉 EP10.0 31、Lactose Monohydrate一水乳糖 EP10.0 32、lsopropyl Alcohol異丙醇 EP10.0 33、Titanium dioxide二氧化鈦 EP10.0 34、Polyethylene glycol 400 聚乙二醇400 EP10.0 35、氨丁三醇 TROMETAMOL EP10.0 36、依地酸鈣鈉 SODIUM CALCIUM EDETATE EP10.0 37、碘帕醇 IOPAMIDOL EP10.0 38、甘露醇 MANNITOL 查EP10.0 39、Macrogol 4000 EP10.0 40、鹽酸二甲雙胍Metformin hydrochloride，EP10.0 41、Polyoxyl castor oil EP10.0 42、Ascorbic Acid-EP10.0 43、EP10.0中的（5.1.8） 44、EP10.0中的（5.1.4） 45、Carboxymethylcellulose sodium的最新歐洲藥典，然后這個monograph（專著）里面有一個取代度的具體方法。 EP10.0 46、Tranexamic Acid EP10.0 47、歐洲藥典10.0版Starches hydrocyethyl 48、Dextrose和Glucose monohydrate EP10標準 49、Oxcarbazepine EP10標準 50、Human albumin solution EP10標準 51、Cefoperazone Sodium EP10.0 52、Sulbactam Sodium EP10.0 53、Azithromycin、 EP10標準 54、Aripiprazole EP10.0 55、 Candesartan cilexetil EP10.0 56、Clopidogrel besilate EP10.0 57、Clopidogrel hydrogen sulfate EP10.0 58、Clopidogrel hydrochloride EP10.0 59、Duloxetine hydrochloride EP10.0 60、Galantamine hydrobromide EP10.0 61、Irbesartan EP10.0 62、Olmesartan medoxomil EP10.0 63、Pemetrexed disodium heptahydrate EP10.0 64、Pramipexole dihydrochloride monohydrate EP10.0 65、Prasugrel hydrochloride EP10.0 66、Tamsulosin hydrochlorideEP10.0 67、孟魯司特鈉（Montelukast sodium）EP10.0 68、孟魯司特鈉片（Montelukast Sodium Tablets）EP10標準 69、Sodium Benzoate EP10.0 70、Propylene Glycol EP10.0 71、Citric Acid Monohydrate EP10.0 72、Citric Acid Hydrate EP10標準 EP10.0 73、Sodium Citrate EP10標準 74、奧美拉唑鈉Omeprazole sodium的質(zhì)量標準 EP10.0 75、最新版歐洲藥典里的枸櫞酸質(zhì)量標準 EP10.0 76、Sodium dihydrogen phosphate dihydrate EP最新版的。 文獻： 1、The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study. 2、Preparation of Polytosylated γ-Cyclodextrins Yamamura Hatsuo 1 , Kawase Yoshitaka 1 , Kawai Masao 1 , Butsugan Yasuo 1 3、Fan GP et at, Human Molecular Genetics, 2010, V19:4231. 4、薬剤の臨床 更年期障害ならびに卵巣欠落癥狀に対するtofisopamの臨床評価，小林拓郎　他：産科と婦人科 49 （2）, 120（1982） 試試這個日文文獻 5、二重盲検法によるEGYT-341（Tofisopam）とDiazepamとの薬効比較，臨牀と研究 58(9): 3029-3041, 1981. 6、Tofisopam(MER-19)の自律神経失調(diào)癥に対する二重盲検比較試験成績，臨牀と研究 62(12): 4045-4060, 1985. 7、頭部?頸部損傷ならびに頸椎疾患に対するTofisopamの臨床的検討―二重盲検法によるγ-oryzanolとの薬効比較―，臨牀と研究 60(6): 2093-2104, 1983. 8、Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial 9、Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry. 2002; 63: 225–31 10、Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria 11、Robert D. Leone,?Liang Zhao,?Judson M. Englert, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion[J]. Science, 2019. 12、The Adverse Effect Profile and Efficacy of Divalproex Sodium Compared With Valproic Acid: A Pharmacoepidemiology Study 13、Gastrointestinal tolerance of divalproex sodium 14、臨床實踐指南:原發(fā)性腎上腺皮質(zhì)功能不全的診斷和治療 (2016版) 15、《歐洲原發(fā)性腎上腺皮質(zhì)功能減退癥的診斷, 治療和隨訪共識 (2013版) 》 16、《臨床實踐指南:腎上腺皮質(zhì)功能不全 (包括腎上腺危象) 的診斷和治療 (2016版) 》 17、? 2019 Solid Oral Dose Process Validation, Volume Two Lifecycle Approach Application Authors: Pazhayattil, A., Sayeed-Desta, N., Fredro-Kumbaradzi, E., Ingram, M., Collins, J. 18、See 1 citation found by title matching your search: Nihon Rinsho. 1988 Jan;46(1):18-24. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; muscarine M1 receptor blockaders]. [Article in Japanese] 19、Journal of the American Chemical Society, 1981, vol. 103, # 9, p. 2361 - 2371 20、Hanish SI, Stein DM, Scalea JR, Essien EO, Thurman P, Hutson WR, et al. Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure. Ann Surg. 2017;266(4):677-84. 21、Infant with 3β-hydroxy-△5-C27 steroid dehydrogenase deficiency：report of two cases and literatures review 22、 A case of congenital bile acid synthesis disorder type 2 and literature review ------ 一例先天性膽汁酸合成障礙2型患兒的臨床及遺傳學分析 Clinical feature and genetic analysis of a family affected by congenital bile acid synthesis defect type 2: identification of 2 novel mutations in AKR1D1 gene 23、Clinical features of a Chinese infant with inborn error of bile acid metabolism 3β-hydroxy-△5-C27 steroid dehydrogenase deficiency and review of the literature 24、3B-hydroxy-△5-C27 steroid dehydrogenase deficiency in one famny：two cases report 25、Iddon, Brian; Nicholas, Martin Journal of the Chemical Society - Perkin Transactions 1, 1996, # 12 p. 1341 - 1347/2、Vereshchagin, L. I.; Maksikova, A. V.; Tikhonova, L. G.; Buzilova, S. R.; Sakovich, G. V. 26、Chemistry of Heterocyclic Compounds (New York, NY, United States), 1981 , vol. 17, # 5 p. 510 - 515 Khimiya Geterotsiklicheskikh Soedinenii, 1981 , # 5 p. 688 - 693 27、3B-hydroxy-△5-C27 steroid dehydrogenase deficiency: a case report